NO137094C - Analogifremgangsm}te til fremstilling av terapeutisk aktive 6-aza-3h-1,4-benzodiazepiner. - Google Patents

Analogifremgangsm}te til fremstilling av terapeutisk aktive 6-aza-3h-1,4-benzodiazepiner.

Info

Publication number: NO137094C
Authority: NO; Norway
Prior art keywords: benzodiazepines; aza; preparation; therapeutic active; analogical procedure
Prior art date: 1971-12-09

Application number

NO4536/72A

Other languages

English (en)

Other versions

NO137094B (no

Inventor

Walter Von Bebenburg

Heribert Offermanns

Original Assignee

Degussa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1971-12-09

Filing date

1972-12-08

Publication date

1977-12-28

1972-12-08 Application filed by Degussa filed Critical Degussa

1977-09-19 Publication of NO137094B publication Critical patent/NO137094B/no

1977-12-28 Publication of NO137094C publication Critical patent/NO137094C/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

NO4536/72A 1971-12-09 1972-12-08 Analogifremgangsm}te til fremstilling av terapeutisk aktive 6-aza-3h-1,4-benzodiazepiner. NO137094C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AT1060471A AT333284B (de)	1971-12-09	1971-12-09	Verfahren zur herstellung von neuen 6-aza-3h-1,4-benzodiazepinen, deren optischen isomeren und deren salzen

Publications (2)

Publication Number	Publication Date
NO137094B NO137094B (no)	1977-09-19
NO137094C true NO137094C (no)	1977-12-28

Family

ID=3623479

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO4536/72A NO137094C (no)	1971-12-09	1972-12-08	Analogifremgangsm}te til fremstilling av terapeutisk aktive 6-aza-3h-1,4-benzodiazepiner.

Country Status (26)

Country	Link
JP (4)	JPS569509B2 (no)
AR (3)	AR201201A1 (no)
AT (4)	AT333284B (no)
AU (1)	AU473253B2 (no)
BE (1)	BE792541A (no)
CH (4)	CH603644A5 (no)
CS (1)	CS212736B2 (no)
DD (1)	DD105448A5 (no)
DE (1)	DE2259471C2 (no)
DK (1)	DK138425B (no)
EG (1)	EG10918A (no)
ES (2)	ES409090A1 (no)
FI (1)	FI54710C (no)
FR (1)	FR2162482B1 (no)
GB (1)	GB1400755A (no)
HU (1)	HU169468B (no)
IL (1)	IL41034A (no)
IT (1)	IT1035053B (no)
NL (1)	NL171986C (no)
NO (1)	NO137094C (no)
PL (3)	PL91876B1 (no)
RO (4)	RO65263A (no)
SE (1)	SE404803B (no)
SU (4)	SU468423A3 (no)
YU (2)	YU305972A (no)
ZA (1)	ZA728497B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2364636C2 (de) *	1973-12-24	1982-11-04	Degussa Ag, 6000 Frankfurt	Verfahren zur Herstellung von 2-Benzoyl-6-chlor-3-nitro-pyridinen
ATE7295T1 (de) *	1980-01-16	1984-05-15	Lacer, S.A.	2-halo-pyridine, ihre herstellung und pharmazeutische zusammensetzungen.
JPS60132610A (ja) *	1983-12-20	1985-07-15	Japan Organo Co Ltd	汚泥脱水装置
JPS6219221A (ja) *	1985-07-16	1987-01-28	Chiyoda Chem Eng & Constr Co Ltd	原液中の微細粒子を除去する濾過方法と濾過装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3314941A (en) *	1964-06-23	1967-04-18	American Cyanamid Co	Novel substituted pyridodiazepins
US3523939A (en) *	1967-07-03	1970-08-11	Hoffmann La Roche	5-(2,6-disubstituted phenyl)-1,4-benzodiazepines and methods for their preparation

1971
- 1971-12-09 AT AT1060471A patent/AT333284B/de not_active IP Right Cessation
- 1971-12-09 AT AT902174A patent/AT332877B/de active
- 1971-12-09 AT AT902274A patent/AT332878B/de active
1972
- 1972-11-29 ES ES409090A patent/ES409090A1/es not_active Expired
- 1972-11-29 ES ES409089A patent/ES409089A1/es not_active Expired
- 1972-11-30 FI FI3390/72A patent/FI54710C/fi active
- 1972-11-30 ZA ZA728497A patent/ZA728497B/xx unknown
- 1972-12-05 DE DE2259471A patent/DE2259471C2/de not_active Expired
- 1972-12-05 SE SE7215858A patent/SE404803B/xx unknown
- 1972-12-06 HU HUDE799A patent/HU169468B/hu unknown
- 1972-12-06 FR FR7243359A patent/FR2162482B1/fr not_active Expired
- 1972-12-06 EG EG502/72A patent/EG10918A/xx active
- 1972-12-07 IT IT7254583Q patent/IT1035053B/it active
- 1972-12-07 RO RO7281196A patent/RO65263A/ro unknown
- 1972-12-07 RO RO7200073075A patent/RO62312A/ro unknown
- 1972-12-07 PL PL1972175581A patent/PL91876B1/pl unknown
- 1972-12-07 PL PL1972175582A patent/PL91828B1/pl unknown
- 1972-12-07 RO RO7281197A patent/RO67345A/ro unknown
- 1972-12-07 NL NLAANVRAGE7216621,A patent/NL171986C/xx not_active IP Right Cessation
- 1972-12-07 PL PL1972159365A patent/PL89682B1/pl unknown
- 1972-12-07 RO RO7281195A patent/RO65264A/ro unknown
- 1972-12-08 DK DK615172AA patent/DK138425B/da not_active IP Right Cessation
- 1972-12-08 CS CS728424A patent/CS212736B2/cs unknown
- 1972-12-08 IL IL41034A patent/IL41034A/en unknown
- 1972-12-08 YU YU03059/72A patent/YU305972A/xx unknown
- 1972-12-08 BE BE792541A patent/BE792541A/xx not_active IP Right Cessation
- 1972-12-08 GB GB5688372A patent/GB1400755A/en not_active Expired
- 1972-12-08 SU SU1855103A patent/SU468423A3/ru active
- 1972-12-08 NO NO4536/72A patent/NO137094C/no unknown
- 1972-12-09 JP JP12387872A patent/JPS569509B2/ja not_active Expired
- 1972-12-11 DD DD167428A patent/DD105448A5/xx unknown
- 1972-12-11 CH CH1506676A patent/CH603644A5/xx not_active IP Right Cessation
- 1972-12-11 CH CH1794972A patent/CH594665A5/xx not_active IP Right Cessation
- 1972-12-11 CH CH1526076A patent/CH603645A5/xx not_active IP Right Cessation
- 1972-12-11 AU AU49931/72A patent/AU473253B2/en not_active Expired
- 1972-12-11 CH CH1506576A patent/CH605946A5/xx not_active IP Right Cessation
1973
- 1973-09-10 AR AR250008A patent/AR201201A1/es active
1974
- 1974-03-20 AR AR252867A patent/AR200309A1/es active
- 1974-07-08 SU SU742041603A patent/SU674675A3/ru active
- 1974-07-08 SU SU7402042686A patent/SU564809A3/ru active
- 1974-10-15 SU SU7402067128A patent/SU574156A3/ru active
- 1974-10-31 AR AR256352A patent/AR203311A1/es active
- 1974-11-11 AT AT902074A patent/AT338798B/de not_active IP Right Cessation
1980
- 1980-04-15 JP JP5022280A patent/JPS55147282A/ja active Granted
- 1980-04-15 JP JP5022380A patent/JPS5625181A/ja active Granted
- 1980-04-15 JP JP5022180A patent/JPS5625180A/ja active Granted
1981
- 1981-05-07 YU YU01168/81A patent/YU116881A/xx unknown

Also Published As

Publication number	Publication date
JPS5742638B2 (no)	1982-09-09
ATA902274A (de)	1976-02-15
RO65264A (fr)	1979-08-15
FR2162482B1 (no)	1976-03-05
GB1400755A (en)	1975-07-23
NO137094B (no)	1977-09-19
FI54710B (fi)	1978-10-31
AR200309A1 (es)	1974-10-31
ATA902174A (de)	1976-02-15
IL41034A0 (en)	1973-02-28
HU169468B (no)	1976-11-28
YU116881A (en)	1984-02-29
SU468423A3 (ru)	1975-04-25
SE404803B (sv)	1978-10-30
JPS5744678B2 (no)	1982-09-22
CH605946A5 (no)	1978-10-13
IT1035053B (it)	1979-10-20
JPS4864096A (no)	1973-09-05
DE2259471C2 (de)	1982-08-19
DK138425B (da)	1978-09-04
RO62312A (fr)	1977-12-15
DE2259471A1 (de)	1973-06-14
PL89682B1 (en)	1976-12-31
PL91828B1 (en)	1977-03-31
SU674675A3 (ru)	1979-07-15
CH594665A5 (no)	1978-01-13
IL41034A (en)	1976-10-31
AR203311A1 (es)	1975-08-29
JPS5742639B2 (no)	1982-09-09
AT338798B (de)	1977-09-12
CH603644A5 (no)	1978-08-31
CS212736B2 (en)	1982-03-26
JPS5625181A (en)	1981-03-10
AT333284B (de)	1976-11-10
JPS569509B2 (no)	1981-03-02
JPS55147282A (en)	1980-11-17
DD105448A5 (no)	1974-04-20
AT332877B (de)	1976-10-25
PL91876B1 (en)	1977-03-31
JPS5625180A (en)	1981-03-10
FI54710C (fi)	1979-02-12
DK138425C (no)	1979-02-12
AR201201A1 (es)	1975-02-21
SU564809A3 (ru)	1977-07-05
AT332878B (de)	1976-10-25
NL7216621A (no)	1973-06-13
ATA1060471A (de)	1976-03-15
RO67345A (ro)	1980-07-15
EG10918A (en)	1981-12-31
BE792541A (fr)	1973-06-08
ZA728497B (en)	1973-09-26
ES409089A1 (es)	1975-10-16
SU574156A3 (ru)	1977-09-25
NL171986B (nl)	1983-01-17
AU4993172A (en)	1974-06-13
RO65263A (ro)	1983-07-07
RO65263B (ro)	1983-06-30
ES409090A1 (es)	1975-10-16
AU473253B2 (en)	1976-06-17
FR2162482A1 (no)	1973-07-20
YU305972A (en)	1982-02-28
NL171986C (nl)	1983-06-16
ATA902074A (de)	1977-01-15
CH603645A5 (no)	1978-08-31

Publication	Publication Date	Title
NO136793C (no)	1977-11-09	Analogifremgangsm}te til fremstilling av terapeutisk virksomme substituerte 1,2,4-triazolderivater.
NO136459C (no)	1977-09-07	Analogifremgangsm}te for fremstilling av antimikrobielt virksomme pleuromutiliner.
SE389331B (sv)	1976-11-01	Forfarande for framstellning av vissa angivna 2,2-metylendifenoler.
NO136045C (no)	1977-07-13	Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazinoner.
NO138566C (no)	1978-09-27	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
NO140977C (no)	1979-12-19	Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner
NO740606L (no)	1974-08-26	Analogifremgangsmåte til fremstilling av terapeutisk virksomme 3-klor-7-alfa-amino-acylcefalosporinforbindelser.
NO147916C (no)	1983-07-06	Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser.
NO141850C (no)	1980-06-04	Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO136251C (no)	1977-08-10	Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater.
NO139088C (no)	1979-01-03	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner
NO136795C (no)	1977-11-09	Analogifremgangsm}te for fremstilling av terapeutisk aktive indoliner
NO136574C (no)	1977-09-28	Analogifremgangsm}te for fremstilling av terapeutisk aktive pyrimidinderivater.
NO740607L (no)	1974-08-26	Analogifremgangsmåte til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser.
NO137094C (no)	1977-12-28	Analogifremgangsm}te til fremstilling av terapeutisk aktive 6-aza-3h-1,4-benzodiazepiner.
SE398501B (sv)	1977-12-27	Analogiforfarande for framstellning av 1,4-bensodiazepinderivat
SE406587B (sv)	1979-02-19	Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin
NO137093C (no)	1977-12-28	Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner
NO140104C (no)	1979-07-11	Analogifremgangsmaate til fremstilling av 17beta-hydroksy-16,16-dimetylestr-4-en-3-on med terapeutisk aktivitet
NO136410C (no)	1977-08-31	Analogifremgangsm}te til fremstilling av antidiabetisk virksomme 3-metyl-pyrazol-5-karboksamider.
NO136046C (no)	1977-07-13	Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner.
NO138568C (no)	1978-10-04	Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 21-(bea-benzoylaminoisobutyryl)-16alfa,17alfa-(p-dimethyl-aminobenzyliden)-triamcinolon
NO136198C (no)	1977-08-03	Analogifremgangsm}te ved fremstilling av terapeutisk aktivt 16-carboxy-17-methoxy-eburnan.
NO137896C (no)	1978-05-16	Analogifremgangsmaate til fremstilling av terapeutisk virksomme, optisk aktive 1,4-benzodiazepiner
NO138147C (no)	1978-07-12	Analogifremgangsmaate ved fremstilling av terapeutisk aktive 15alfa,16alfa-methylen-4-pregnener